oltipraz has been researched along with Neoplasms in 13 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 4 (30.77) | 18.2507 |
2000's | 9 (69.23) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Munday, R; Zhang, Y | 1 |
Fishbein, JC; Holland, R; Kensler, TW; Navamal, M; Velayutham, M; Zweier, JL | 1 |
Batist, G; Fotouhi-Ardakani, N; Hamilton, D | 1 |
Sudakin, DL | 1 |
Baumgartner, KJ; Bodreddigari, S; Curphey, TJ; Gange, SJ; Kensler, TW; Li, Y; Roebuck, BD; Sutter, TR; Yan, J | 1 |
Chu, H; Cole, SR; Nie, L | 1 |
Fishbein, JC; McCraken, J; Muthukumaran, RB; Sostaric, JZ; Velayutham, M; Zweier, JL | 1 |
Groopman, JD; Kensler, TW; Roebuck, BD | 1 |
Helzlsouer, KJ; Kensler, TW | 1 |
Clapper, ML; Szarka, CE | 1 |
Curphey, TJ; Groopman, JD; Kensler, TW; Roebuck, BD; Sutter, TR | 1 |
Bagnasco, M; Bennicelli, C; Camoirano, A; Cartiglia, C; De Flora, S; Egner, PA; Jacobson, LP; Kensler, TW; Qian, GS; Wang, JB; Zhang, BC; Zhu, YR | 1 |
Biswas, S; Das, SK; Gairola, CG | 1 |
7 review(s) available for oltipraz and Neoplasms
Article | Year |
---|---|
Dithiolethiones for cancer chemoprevention: where do we stand?
Topics: Animals; Anticarcinogenic Agents; Chemoprevention; Humans; Models, Biological; Neoplasms; Pyrazines; Thiones; Thiophenes | 2008 |
The glutathione system in alkylator resistance.
Topics: Alkylating Agents; Anticarcinogenic Agents; Buthionine Sulfoximine; Enzyme Inhibitors; Ethacrynic Acid; Glutamate-Cysteine Ligase; Glutathione; Glutathione Synthase; Humans; Neoplasms; Pyrazines; Thiones; Thiophenes | 2002 |
Dietary aflatoxin exposure and chemoprevention of cancer: a clinical review.
Topics: Aflatoxins; Animals; Anticarcinogenic Agents; Biomarkers; Chlorophyllides; Diet; Humans; Neoplasms; Pyrazines; Reverse Transcriptase Inhibitors; Thiones; Thiophenes | 2003 |
Carcinogen-DNA and protein adducts as intermediate biomarkers for human chemoprotection trials.
Topics: Aflatoxins; Animals; Anticarcinogenic Agents; Biomarkers, Tumor; Carcinogens; DNA; Humans; Liver Neoplasms, Experimental; Neoplasms; Proteins; Pyrazines; Thiones; Thiophenes | 1994 |
Cancer chemoprotection by oltipraz: experimental and clinical considerations.
Topics: Animals; Anticarcinogenic Agents; Clinical Trials as Topic; Drug Screening Assays, Antitumor; Female; Humans; Male; Neoplasms; Neoplasms, Experimental; Pyrazines; Thiones; Thiophenes | 1993 |
Glutathione S-transferases--biomarkers of cancer risk and chemopreventive response.
Topics: Animals; Anticarcinogenic Agents; Biomarkers; Brassica; Colitis, Ulcerative; Colorectal Neoplasms; Disease Models, Animal; Enzyme Induction; Gene Expression; Glutathione Transferase; Humans; Inactivation, Metabolic; Mice; Neoplasms; Pyrazines; Risk Factors; Thiones; Thiophenes | 1998 |
Development of cancer chemopreventive agents: oltipraz as a paradigm.
Topics: Animals; Anticarcinogenic Agents; Chemoprevention; Cytochrome P-450 Enzyme System; Drug Approval; Enzyme Induction; Humans; Neoplasms; Pyrazines; Thiones; Thiophenes | 1999 |
1 trial(s) available for oltipraz and Neoplasms
Article | Year |
---|---|
Oltipraz chemoprevention trial in Qidong, People's Republic of China: results of urine genotoxicity assays as related to smoking habits.
Topics: Administration, Oral; Adult; Biomarkers; Chemoprevention; Escherichia coli; Female; Humans; Male; Mutagenicity Tests; Mutagens; Neoplasms; Pyrazines; Reproducibility of Results; Salmonella typhimurium; Smoking; Thiones; Thiophenes; Urine | 2001 |
5 other study(ies) available for oltipraz and Neoplasms
Article | Year |
---|---|
Hydrogen peroxide is a second messenger in phase 2 enzyme induction by cancer chemopreventive dithiolethiones.
Topics: Animals; Antineoplastic Agents; Antioxidants; Cyclic N-Oxides; Diglycerides; Enzyme Induction; Hepatocytes; Humans; Hydrogen Peroxide; NAD(P)H Dehydrogenase (Quinone); Neoplasms; Pyrazines; Second Messenger Systems; Thiones; Thiophenes | 2009 |
Evaluation of the cancer chemopreventive potency of dithiolethione analogs of oltipraz.
Topics: Aflatoxin B1; Animals; Anticarcinogenic Agents; Antioxidants; Blotting, Western; Carcinogens; DNA; DNA Adducts; Dose-Response Relationship, Drug; Electrophoresis, Polyacrylamide Gel; Glutathione Transferase; Immunoblotting; Liver; Male; Models, Chemical; Neoplasms; Nucleic Acid Hybridization; Oligonucleotide Array Sequence Analysis; Pyrazines; Rats; Rats, Inbred F344; RNA; RNA, Messenger; Temperature; Thiones; Thiophenes; Time Factors | 2003 |
A general approach for sample size and statistical power calculations assessing of interventions using a mixture model in the presence of detection limits.
Topics: Anticarcinogenic Agents; Clinical Trials as Topic; Computer Simulation; Humans; Models, Statistical; Monte Carlo Method; Neoplasms; Pyrazines; Sample Size; Thiones; Thiophenes | 2006 |
Interactions of the major metabolite of the cancer chemopreventive drug oltipraz with cytochrome c: a novel pathway for cancer chemoprevention.
Topics: Animals; Anticarcinogenic Agents; Antioxidants; Chemoprevention; Cytochromes c; Electron Spin Resonance Spectroscopy; Electron Transport; Heart; Horses; Mass Spectrometry; Mitochondria; Neoplasms; Oxidation-Reduction; Peroxidase; Pyrazines; Reactive Oxygen Species; Spectrophotometry, Ultraviolet; Thiones; Thiophenes | 2007 |
Oltipraz protects the passive smoke induced changes in renal glyoxalase system of rats.
Topics: Animals; Anticarcinogenic Agents; Female; Kidney; Lactoylglutathione Lyase; Neoplasms; Pyrazines; Rats; Rats, Sprague-Dawley; Thiolester Hydrolases; Thiones; Thiophenes; Tobacco Smoke Pollution | 2002 |